| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Tao Jin | Q88877359 |
| P2093 | author name string | Li Sun | |
| Jie Zhu | |||
| Chao Zheng | |||
| Hudong Liang | |||
| Jinming Han | |||
| Meng-Ge Yang | |||
| P2860 | cites work | A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitis | Q92293255 |
| Innate Immune Cells: Monocytes, Monocyte-Derived Macrophages and Microglia as Therapeutic Targets for Alzheimer's Disease and Multiple Sclerosis | Q92711503 | ||
| NF-κB pathway and the Goldilocks principle: Lessons from human disorders of immunity and inflammation | Q92799594 | ||
| RelB controls adaptive responses of astrocytes during sterile inflammation | Q92917266 | ||
| I-Rel: a novel rel-related protein that inhibits NF-kappa B transcriptional activity | Q24298219 | ||
| IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production | Q24338636 | ||
| Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif | Q24606830 | ||
| Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues | Q24685416 | ||
| Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions | Q26751459 | ||
| Regulatory T cells in autoimmune neuroinflammation | Q26825063 | ||
| Human memory T cells: generation, compartmentalization and homeostasis | Q26851748 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| Role of regulatory b cells in neuroimmunologic disorders | Q28077219 | ||
| Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis | Q28082878 | ||
| Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency | Q28190857 | ||
| BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF | Q28213294 | ||
| Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins | Q28253531 | ||
| A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1 | Q28263524 | ||
| NF-kappaB and the immune response | Q28271031 | ||
| Multiple sclerosis | Q28299151 | ||
| T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma | Q28506783 | ||
| Opposing roles for RelB and Bcl-3 in regulation of T-box expressed in T cells, GATA-3, and Th effector differentiation | Q28513506 | ||
| Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. | Q38227343 | ||
| Regulation of T-cell activation: differences among T-cell subsets | Q38262272 | ||
| Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation | Q38315125 | ||
| Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. | Q38350061 | ||
| RelB+ Steady-State Migratory Dendritic Cells Control the Peripheral Pool of the Natural Foxp3+ Regulatory T Cells | Q38687399 | ||
| Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro. | Q38765786 | ||
| Noncanonical NF-κB Signaling in Health and Disease | Q38779134 | ||
| Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells | Q38798777 | ||
| Central immune tolerance depends on crosstalk between the classical and alternative NF-κB pathways in medullary thymic epithelial cells | Q38849424 | ||
| Tolerogenic dendritic cells. | Q38959180 | ||
| 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology | Q39086011 | ||
| Thymic Epithelial Cells. | Q39146778 | ||
| Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies | Q39188128 | ||
| Stabilization of RelB requires multidomain interactions with p100/p52. | Q39259508 | ||
| Effector and regulatory B cells in Multiple Sclerosis | Q39276276 | ||
| The non-canonical NF-κB pathway in immunity and inflammation | Q39350735 | ||
| Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. | Q39480825 | ||
| Identification of lysine residues critical for the transcriptional activity and polyubiquitination of the NF-kappaB family member RelB. | Q39962315 | ||
| Daxx represses expression of a subset of antiapoptotic genes regulated by nuclear factor-kappaB. | Q40230519 | ||
| Update on disease-modifying therapies for multiple sclerosis | Q40355402 | ||
| Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy | Q40404169 | ||
| An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. | Q40472871 | ||
| Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens. | Q40516749 | ||
| Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control | Q40758278 | ||
| Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. | Q40793043 | ||
| Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity | Q40793381 | ||
| Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene | Q40911408 | ||
| Thymocytes and RelB-dependent medullary epithelial cells provide growth-promoting and organization signals, respectively, to thymic medullary stromal cells | Q41107405 | ||
| Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice | Q41137496 | ||
| The physiology of murine germinal center reactions | Q41492250 | ||
| The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells | Q41522425 | ||
| Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin | Q42029086 | ||
| The effects of RelB deficiency on lymphocyte development and function | Q42428353 | ||
| Critical role of RelB serine 368 for dimerization and p100 stabilization | Q42799106 | ||
| Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. | Q42944465 | ||
| Abnormal Tr1 differentiation in multiple sclerosis | Q42953557 | ||
| Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile | Q43273791 | ||
| RelA and RelB transcription factors in distinct thymocyte populations control lymphotoxin-dependent interleukin-17 production in γδ T cells | Q43695616 | ||
| Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway | Q44074277 | ||
| Multiple sclerosis: involvement of interferons in lesion pathogenesis | Q44269218 | ||
| Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications. | Q45071794 | ||
| RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages | Q45715835 | ||
| SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB. | Q45764061 | ||
| Regulation of naive T cell function by the NF-kappaB2 pathway | Q46071109 | ||
| Insights into immune tolerance from AIRE deficiency | Q46113188 | ||
| Role of the NF-κB Family Member RelB in Regulation of Foxp3+ Regulatory T Cells In Vivo | Q47202229 | ||
| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria | Q47220919 | ||
| Elevated expression of granulocyte-macrophage colony-stimulating factor receptor in multiple sclerosis lesions | Q47228726 | ||
| Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production | Q47309507 | ||
| A TNF-p100 pathway subverts noncanonical NF-κB signaling in inflamed secondary lymphoid organs. | Q47614119 | ||
| RelB regulates Th17 differentiation in a cell-intrinsic manner | Q47627430 | ||
| A link between RelB expression and tumor progression in laryngeal cancer | Q47646877 | ||
| NF-κB2 Controls the Migratory Activity of Memory T Cells by Regulating Expression of CXCR4 in a Mouse Model of Sjögren's Syndrome | Q47957393 | ||
| Pillars article: two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999. 401: 708-712. | Q48094206 | ||
| 1,25-dihydroxyvitamin D3 -induced dendritic cells suppress experimental autoimmune encephalomyelitis by increasing proportions of the regulatory lymphocytes and reducing T helper type 1 and type 17 cells | Q48272380 | ||
| Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis | Q48316951 | ||
| Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells | Q48660181 | ||
| Human T Cell Development, Localization, and Function throughout Life | Q50024233 | ||
| Monomethyl fumarate treatment impairs maturation of human myeloid dendritic cells and their ability to activate T cells | Q50141471 | ||
| Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis. | Q50208033 | ||
| Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) | Q28590962 | ||
| Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| The two NF-kappaB activation pathways and their role in innate and adaptive immunity | Q29614355 | ||
| Germinal centers | Q29616234 | ||
| The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting | Q29618424 | ||
| Regulatory T cells: mechanisms of differentiation and function | Q29620731 | ||
| Revised diagnostic criteria of multiple sclerosis | Q30733519 | ||
| Deficiency of transcription factor RelB perturbs myeloid and DC development by hematopoietic-extrinsic mechanisms. | Q33569314 | ||
| Germinal center B cell development has distinctly regulated stages completed by disengagement from T cell help | Q33675647 | ||
| Chemokines and cell migration in secondary lymphoid organs | Q33807114 | ||
| T cell-intrinsic function of the noncanonical NF-κB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis | Q33827244 | ||
| Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Q33862720 | ||
| The noncanonical NF-κB pathway | Q34031207 | ||
| T-Independent immune response: new aspects of B cell biology | Q34054938 | ||
| Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter. | Q34085202 | ||
| RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF | Q34167602 | ||
| Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
| IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors | Q34384130 | ||
| γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. | Q34434443 | ||
| Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis | Q34575334 | ||
| Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells | Q34628248 | ||
| RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. | Q34660473 | ||
| Dendritic cell control of tolerogenic responses | Q34982085 | ||
| The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. | Q35049530 | ||
| The Role of relB in Regulating the Adaptive Immune Response | Q35119985 | ||
| Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway | Q35216951 | ||
| Activation of dendritic cells: translating innate into adaptive immunity | Q35634014 | ||
| TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression | Q35750113 | ||
| B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells | Q35946128 | ||
| Rank signaling links the development of invariant γδ T cell progenitors and Aire(+) medullary epithelium | Q36011240 | ||
| Natural Th17 cells are critically regulated by functional medullary thymic microenvironments. | Q36062664 | ||
| Journey through the thymus: stromal guides for T-cell development and selection | Q36402237 | ||
| Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis | Q36403957 | ||
| Specialized role of migratory dendritic cells in peripheral tolerance induction | Q36580331 | ||
| B cells in multiple sclerosis therapy-A comprehensive review. | Q50532285 | ||
| RelB/p50 regulates CCL19 production, but fails to promote human DC maturation. | Q50586479 | ||
| Gender and autoimmune comorbidity in multiple sclerosis. | Q51163482 | ||
| The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. | Q51949099 | ||
| Nuclear Factor-kappaB in Autoimmunity: Man and Mouse. | Q52311688 | ||
| Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). | Q52519041 | ||
| Interferon-gamma confers resistance to experimental allergic encephalomyelitis. | Q52520772 | ||
| The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q52615341 | ||
| Skin-Resident T Cells Drive Dermal Dendritic Cell Migration in Response to Tissue Self-Antigen. | Q52644128 | ||
| Setting Up the Perimeter of Tolerance: Insights into mTEC Physiology. | Q52752332 | ||
| The role of Th17 cells in auto-inflammatory neurological disorders. | Q53391537 | ||
| The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. | Q53453365 | ||
| Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. | Q53575380 | ||
| Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. | Q53654834 | ||
| BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. | Q53664665 | ||
| IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines. | Q54061278 | ||
| Lentiviral-mediated shRNA against RelB induces the generation of tolerogenic dendritic cells. | Q54327976 | ||
| B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. | Q54707196 | ||
| TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. | Q54707207 | ||
| Multiple Sclerosis: Mechanisms and Immunotherapy. | Q55060344 | ||
| The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells. | Q55512935 | ||
| T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention | Q56582190 | ||
| T cell tolerance by clonal elimination in the thymus | Q56922465 | ||
| An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway | Q57230082 | ||
| Multiple sclerosis | Q58586681 | ||
| Role of nuclear factor κB in multiple sclerosis and experimental autoimmune encephalomyelitis | Q58775945 | ||
| RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells | Q59340722 | ||
| The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models | Q61812996 | ||
| Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity | Q64236635 | ||
| Multiple Sclerosis: B Cells Take Center Stage. | Q64968463 | ||
| A pathogenic role for gamma delta T cells in relapsing-remitting experimental allergic encephalomyelitis in the SJL mouse | Q71384783 | ||
| IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis | Q71687717 | ||
| Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells | Q72678853 | ||
| The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii | Q73050577 | ||
| Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells | Q73396313 | ||
| Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines | Q74321402 | ||
| Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? | Q74675085 | ||
| RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells | Q77769122 | ||
| Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis | Q79264742 | ||
| IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis | Q79755041 | ||
| Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response | Q80209390 | ||
| B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism | Q81317325 | ||
| Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection | Q83781715 | ||
| B cells in multiple sclerosis | Q88305700 | ||
| Noncanonical NF-κB in Cancer | Q89011918 | ||
| RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory Cells | Q90440475 | ||
| γδ T lymphocytes in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis | Q92113981 | ||
| Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity | Q92272801 | ||
| B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel. | Q36675058 | ||
| IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. | Q36742236 | ||
| T(H)-17 cells in the circle of immunity and autoimmunity | Q36765453 | ||
| RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. | Q36812702 | ||
| Mechanisms regulating regional localization of inflammation during CNS autoimmunity. | Q36918129 | ||
| Regulatory T cells - a brief history and perspective | Q36986732 | ||
| Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions | Q37018185 | ||
| The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways | Q37029918 | ||
| Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination | Q37053851 | ||
| Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins | Q37102527 | ||
| Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development | Q37181833 | ||
| RelB: an outlier in leukocyte biology | Q37238291 | ||
| Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation | Q37250352 | ||
| B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation. | Q37314912 | ||
| Secondary lymphoid organs: responding to genetic and environmental cues in ontogeny and the immune response | Q37397090 | ||
| Relb acts downstream of medullary thymic epithelial stem cells and is essential for the emergence of RANK(+) medullary epithelial progenitors. | Q37404661 | ||
| The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance | Q37459848 | ||
| Disease-modifying agents in the treatment of multiple sclerosis: a review of long-term outcomes. | Q37610482 | ||
| In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses. | Q37652977 | ||
| The NF-kappaB family of transcription factors and its regulation | Q37672294 | ||
| Mouse models for multiple sclerosis: historical facts and future implications | Q37769907 | ||
| Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies | Q37771933 | ||
| T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. | Q37777431 | ||
| New insights into the development of lymphoid tissues | Q37779724 | ||
| A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis | Q37818921 | ||
| Non-canonical NF-κB signaling pathway | Q37822660 | ||
| Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. | Q37845414 | ||
| Non-canonical NF-κB signaling activation and regulation: principles and perspectives | Q37948121 | ||
| Development and function of interleukin 17-producing γδ T cells | Q37975296 | ||
| Thymic epithelial cells: working class heroes for T cell development and repertoire selection | Q38010575 | ||
| TNF receptor family signaling in the development and functions of medullary thymic epithelial cells | Q38042619 | ||
| Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis | Q38114422 | ||
| T-bet: a bridge between innate and adaptive immunity. | Q38151473 | ||
| Cell-based modulation of autoimmune responses in multiple sclerosis and experimental autoimmmune encephalomyelitis: therapeutic implications | Q38213879 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 115 | |
| P577 | publication date | 2019-12-27 | |
| P1433 | published in | Molecular Brain | Q6895938 |
| P1476 | title | Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis | |
| P478 | volume | 12 |
Search more.